Tag Archives: Certain

Increase of Certain Fatty Acids Can Help Reduce Migraine Severity

Migraine is among the biggest reasons for disability worldwide. Current treatment options are sometimes inadequate for providing complete relief for sufferers. Research has found that a change in diet provides one more option sufferers are able to use in their attempt to have less headaches and migraines. Polyunsaturated fatty acids, which the body doesn’t produce,… Read More »

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a… Read More »

FDA Approves Merck’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers

Print this page KENILWORTH, N.J.–(BUSINESS WIRE) June 12, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Gardasil 9 for the prevention of oropharyngeal and other head and neck cancers caused by HPV Types… Read More »